Abstract
We appreciate Dr. Jianmin Huang letter [1] and interest in our work, as well as the important comments provided for our retrospective cohort study entitled “Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19” published in Digestive and Liver Disease.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
